Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Dysmyelopoietic Syndromes

tetradecanoylphorbol acetate has been researched along with Dysmyelopoietic Syndromes in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (60.00)18.2507
2000's4 (26.67)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Brings, C; Cadeddu, P; Fröbel, J; Gattermann, N; Germing, U; Haas, R1
Cen, J; Chen, Y; Chen, Z; Ding, X; Qi, X; Shen, H; Wang, Y; Yao, L1
Cen, J; Chen, Z; Gu, M; Liu, D; Qi, X1
Aplan, PD; Lin, YW; Slape, C; Zhang, Z1
Chow, S; Hedley, D; Tong, FK1
Barckow, P; Fiebeler, A; Graham, DK; Huhn, D; Neubauer, A; O'Bryan, JP; Schmidt, CA; Serke, S; Siegert, W; Snodgrass, HR1
Asai, T; Itoh, K; Oh, H; Wakita, H; Yoshida, S1
Dang, Y; Edwards, SW; Galvani, DW; Lowe, GM; Watson, F1
Dang, Y; Edwards, SW; Galvani, DW; Lowe, GM1
Eisterer, W; Greil, R; Hilbe, W; Ludescher, C; Thaler, J; Zabernigg, A1
Koide, Y; Nakamura, S; Ohnishi, K; Ohno, R; Shinjo, K; Takeshita, A; Tohyama, K; Yoshida, H1
Acs, G; Banerjee, R; Bekesi, JG; Choi, HS; Deak, G; Holland, JF; Paronetto, F; Sperber, K; Tarcsafalvi, A1
Aizawa, S; Itoh, Y; Kuratsuji, T; Ohyashiki, K; Sai, M; Toyama, K1
Ishikura, H; Sakane, T; Tsuchida, T; Tsunematsu, T1
Kakinuma, K; Kaneda, M; Komiya, I; Kuriya, S; Nomura, T; Saito, Y; Shinohara, T; Tanoue, K1

Trials

1 trial(s) available for tetradecanoylphorbol acetate and Dysmyelopoietic Syndromes

ArticleYear
Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells.
    Cytometry. Part B, Clinical cytometry, 2006, Volume: 70, Issue:3

    Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Benzenesulfonates; CD13 Antigens; CD3 Complex; Drug Monitoring; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Hemolysis; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; MAP Kinase Signaling System; Middle Aged; Models, Biological; Myelodysplastic Syndromes; Neoplasms; Niacinamide; Phenylurea Compounds; Phosphorylation; Pyridines; Sialic Acid Binding Ig-like Lectin 3; Sorafenib; Stem Cell Factor; Stem Cells; Tetradecanoylphorbol Acetate

2006

Other Studies

14 other study(ies) available for tetradecanoylphorbol acetate and Dysmyelopoietic Syndromes

ArticleYear
Impaired formation of neutrophil extracellular traps in patients with MDS.
    Blood advances, 2022, 01-11, Volume: 6, Issue:1

    Topics: Extracellular Traps; Humans; Hydrogen Peroxide; Myelodysplastic Syndromes; Neutrophils; Tetradecanoylphorbol Acetate

2022
BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:6

    Topics: Acetylation; Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Butyric Acid; Case-Control Studies; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Histamine Antagonists; Histones; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes; Nuclear Proteins; Polycomb Repressive Complex 1; Protein Binding; Proto-Oncogene Proteins c-fos; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Young Adult

2014
Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
    International journal of molecular medicine, 2008, Volume: 22, Issue:1

    Topics: Adult; Aged; Antigens, CD34; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium-Binding Proteins; Cell Cycle; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; K562 Cells; Leukemia; Leukocytes, Mononuclear; Male; Membrane Proteins; Middle Aged; Myelodysplastic Syndromes; Oligonucleotide Array Sequence Analysis; Oxides; Tetradecanoylphorbol Acetate; Up-Regulation

2008
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.
    Blood, 2005, Jul-01, Volume: 106, Issue:1

    Topics: Acute Disease; Animals; Carcinogens; Cell Differentiation; Cell Transformation, Neoplastic; Disease Models, Animal; Homeodomain Proteins; Humans; K562 Cells; Leukemia; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelodysplastic Syndromes; Myeloid Ecotropic Viral Integration Site 1 Protein; Neoplasm Proteins; Nuclear Pore Complex Proteins; Penetrance; Phenotype; Severity of Illness Index; Tetradecanoylphorbol Acetate; Transcription Factors; Translocation, Genetic

2005
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
    Blood, 1994, Sep-15, Volume: 84, Issue:6

    Topics: Axl Receptor Tyrosine Kinase; Base Sequence; Bone Marrow; Cell Differentiation; Flow Cytometry; Gene Expression; Hematopoiesis; Humans; Interferon-alpha; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Molecular Sequence Data; Monocytes; Myelodysplastic Syndromes; Oncogene Proteins; Polymerase Chain Reaction; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA-Directed DNA Polymerase; RNA, Messenger; Tetradecanoylphorbol Acetate

1994
Chemiluminescence of neutrophils in patients with myeloproliferative or myelodysplastic hematologic diseases--relation to neutrophil alkaline phosphatase activity.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:3

    Topics: Alkaline Phosphatase; Cells, Cultured; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Luminescent Measurements; Myelodysplastic Syndromes; Myeloproliferative Disorders; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate; Thrombocythemia, Essential

1993
Identification of a subgroup of myelodysplastic patients with a neutrophil stimulation-signalling defect.
    British journal of haematology, 1994, Volume: 86, Issue:4

    Topics: Blood Bactericidal Activity; Calcium; Cells, Cultured; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Luminescent Measurements; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Superoxides; Tetradecanoylphorbol Acetate

1994
The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils.
    Leukemia research, 1993, Volume: 17, Issue:12

    Topics: Anemia; Cytochalasin B; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Kinetics; Leukemia, Myelomonocytic, Chronic; Luminescent Measurements; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Recombinant Proteins; Reference Values; Superoxides; Tetradecanoylphorbol Acetate

1993
Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes.
    Leukemia & lymphoma, 1997, Volume: 27, Issue:1-2

    Topics: Adult; Aged; Aged, 80 and over; Cytokines; Female; Granulocytes; Humans; Male; Middle Aged; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; Respiratory Burst; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1997
Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF.
    Cytokines, cellular & molecular therapy, 2000, Volume: 6, Issue:2

    Topics: Antigens, CD; Cell Differentiation; Cell Division; Cell Line; DNA; DNA, Complementary; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Granulocytes; Green Fluorescent Proteins; Humans; Interleukin-3; Luminescent Proteins; Macrophage-1 Antigen; Myelodysplastic Syndromes; Receptors, Granulocyte Colony-Stimulating Factor; Recombinant Proteins; Retroviridae; Tetradecanoylphorbol Acetate; Thymidine; Transfection

2000
Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aged; Animals; Antigens, CD; Blotting, Northern; HIV-1; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Chronic; Male; Mice; Mice, Nude; Microscopy, Electron; Myelodysplastic Syndromes; Neoplasm Transplantation; Plasmids; Protein Kinase C; Proviruses; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Virus Replication

1992
Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndrome.
    Annals of hematology, 1991, Volume: 63, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cytochrome b Group; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate

1991
Impairment of lymphocyte function in patients with myelodysplastic syndrome and its correction by addition of Ca2+ ionophore and phorbol myristate acetate.
    International journal of hematology, 1991, Volume: 54, Issue:6

    Topics: Aged; Aged, 80 and over; Humans; Ionomycin; Longitudinal Studies; Lymphocytes; Middle Aged; Myelodysplastic Syndromes; Tetradecanoylphorbol Acetate

1991
Superoxide anion hyperproduction by neutrophils in a case of myelodysplastic syndrome. Association with Sweet's syndrome and interstitial pneumonia.
    Cancer, 1991, May-01, Volume: 67, Issue:9

    Topics: Dermatitis; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Myristic Acid; Myristic Acids; Neutrophils; Prednisone; Pulmonary Fibrosis; Superoxides; Tetradecanoylphorbol Acetate; Zymosan

1991